LONDON, UK: Mageleka Inc, the developer of new instrumentation has introduced the commercialization of its new RelaxoMeter designed particularly to aid researchers speed up the event of new batteries.
Commentating today, David Fairhurst, Executive Vice President of Mageleka said: “We have used the RelaxoMeter to optimize key constituents of batteries such as carbon blacks and polymerics. To date, most researchers have to optimize by trial and error however the RelaxoMeter now provides formulators with a quick, non-destructive way to measure the impact of particular person components in complex mixtures utilized in battery development”.
Professor Terrence Cosgrove, Chief Scientific Officer added: “The RelaxoMeter is the primary in a brand new series of bench top devices focused on analyzing and characterizing particle suspensions utilizing non-invasive techniques which function in minutes and supply new insights for battery development. We have been developing merchandise for the final 4 years ensuring robustness and reproducibility earlier than providing them to the market. Our state-of-the-art technology is based on low field magnetic resonance and the devices are small and lightweight.”
“We have RelaxoMeter’s in inventory for demonstration and have data for carbon black and polymers utilized in batteries which we’re delighted to share. We additionally offer full scientific support from our founders and pride ourselves in after-market support” said Keith Sanderson, Vice President of European Sales.
Mageleka is a private firm based by three skilled entrepreneurs, scientists, and engineers who’ve developed companies and merchandise from starting through commercialization and IPO. The mixture of experience in magnetic resonance, colloids formulation and finance positions Mageleka for rapid growth. www.mageleka.com